Hypotension after induction of anesthesia with remimazolam or etomidate: a non-inferiority randomized controlled trial in patients undergoing coronary artery bypass grafting
Jeong Jin Min,
No information about this author
Eun Jung Oh,
No information about this author
Hyun Ji Hwang
No information about this author
et al.
Korean journal of anesthesiology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 3, 2025
Remimazolam
is
a
novel
ultra-short-acting
benzodiazepine
known
for
its
hemodynamic
stability
over
propofol.
However,
effects
compared
to
those
of
etomidate
are
not
well
established.
This
study
aimed
determine
whether
the
use
remimazolam
non-inferior
with
regard
occurrence
post-induction
hypotension
in
patients
undergoing
coronary
arterial
bypass
grafting.
Language: Английский
A review of recent advances in anesthetic drugs for patients undergoing cardiac surgery
Yutian Sun,
No information about this author
Xiangyou Sun,
No information about this author
Haibo Wu
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 18, 2025
Inducing
and
maintaining
general
anesthesia
requires
a
diverse
set
of
medications.
Currently,
heart
surgery
anesthetic
management
does
not
adhere
to
any
one
standard
protocol
or
drugs.
To
ensure
steady
circulatory
function
while
providing
sufficient
sedation,
medications
are
carefully
selected
for
cardiovascular
operations.
Among
the
opioids
used
most
often
in
cardiac
fentanyl,
sufentanil,
remifentanil.
As
anesthesiologist,
your
key
responsibilities
will
be
maintain
patient's
blood
pressure
(BP)
oxygen
levels,
reduce
frequency
intensity
ischemia
events,
make
it
easy
them
get
off
cardiopulmonary
bypass
(CPB)
supplemental
fast.
Additionally,
new
knowledge
gaps
have
been
identified
as
result
developments
anesthetics,
which
must
addressed.
The
goal
recent
has
decrease
risks
increase
accuracy
patient
outcomes
during
surgeries.
Furthermore,
methods
tools
contributing
evolution
toward
more
dynamic,
patient-centered
approach,
with
an
eye
on
boosting
safety,
decreasing
complications,
facilitating
better
recovery
patients.
New
emerged
field
pharmacology,
aiming
improve
management,
particularly
patients
who
disease.
Optimal
stability,
fewer
side
effects,
enhanced
surgical
achieved
by
use
these
We
reviewed
all
different
kinds
techniques
this
research.
also
examined
many
medicines
that
produced
individuals
issues.
Next,
we
covered
prospects
realm
novel
Language: Английский
The Efficacy and Safety of Remimazolam Tosilate compared with Propofol for Endoscopic Retrograde Cholangiopancreatography under Monitored Anesthesia Care: A Single-Center Randomized Controlled Clinical Trial
Biyun Zhou,
No information about this author
Shiyong Li,
No information about this author
Ailin Luo
No information about this author
et al.
Heliyon,
Journal Year:
2024,
Volume and Issue:
10(19), P. e38349 - e38349
Published: Sept. 24, 2024
Language: Английский
Letter to the editor regarding “Effect of remimazolam versus propofol on hypotension after anesthetic induction in patients undergoing coronary artery bypass grafting: A randomized controlled trial”
Journal of Clinical Anesthesia,
Journal Year:
2024,
Volume and Issue:
99, P. 111644 - 111644
Published: Sept. 30, 2024
Language: Английский
Response to comment on: “Effect of remimazolam versus propofol on hypotension after anesthetic induction in patients undergoing coronary artery bypass grafting: A randomized controlled trial”
Journal of Clinical Anesthesia,
Journal Year:
2024,
Volume and Issue:
99, P. 111643 - 111643
Published: Oct. 1, 2024
Language: Английский
Letter to the editor regarding “Effect of remimazolam versus propofol on hypotension after anesthetic induction in patients undergoing coronary artery bypass grafting: A randomized controlled trial”.
Jie Wang,
No information about this author
Xiaocou Wang,
No information about this author
Congcong Huang
No information about this author
et al.
Journal of Clinical Anesthesia,
Journal Year:
2024,
Volume and Issue:
99, P. 111658 - 111658
Published: Oct. 17, 2024
Language: Английский
Recent Advances in Understanding the Pathophysiology and Risk Stratification of Post-Intubation Hypotension
Asploro Journal of Biomedical and Clinical Case Reports,
Journal Year:
2024,
Volume and Issue:
8(1), P. 20 - 29
Published: Dec. 18, 2024
Research
indicates
that
post-intubation
hypotension
(PIH)
is
the
most
frequent
complication
of
intubation,
potentially
leading
to
acute
myocardial
infarction,
renal
failure,
extended
hospitalizations,
and
poor
outcomes.
Key
physiological
parameters
such
as
age,
body
mass
index,
baseline
blood
pressure
are
closely
linked
PIH
incidence.
Induction
drugs
significantly
influence
mechanisms
PIH,
with
varying
administration
methods
impacting
hemodynamic
stability.
Furthermore,
complexity
intubation
procedure
exacerbates
by
stimulating
vagus
nerve
affecting
cardiac
output.
Although
current
research
aims
identify
risk
factors
absence
uniform
diagnostic
criteria
impedes
comparability
results.
Future
studies
should
focus
on
establishing
clear
standards,
optimizing
induction
drug
choices
procedural
techniques,
integrating
early
warning
indicators
personalized
intervention
strategies
decrease
incidence
enhance
patient
Language: Английский